6505--Colchicine Tablets

The Department of Veterans Affairs National Acquisition Center is seeking to establish a pharmaceutical supply contract for Colchicine 0.6MG Tablets, with solicitation number 36E79725R0034. The procurement aims to secure a contract for two package sizes: 100-tablet and 1000-tablet bottles, with estimated annual requirements spanning multiple federal agencies including VA, DoD, Indian Health Service, and Bureau of Prisons. Offerors must submit pricing for a base year and four subsequent option years, include a 0.5% Cost Recovery Fee, and provide a unique 11-digit NDC number. Vendors must meet FDA current Good Manufacturing Practices requirements and comply with Drug Supply Chain Security Act regulations. The solicitation closing date has been amended to June 12, 2025, at 2:30 PM Central Daylight Time, with authorized negotiators required to complete and submit all offer documents by this deadline.

The contract is set aside for small businesses with a size standard of 1,300 employees, and will be distributed through Pharmaceutical Prime Vendor programs. While specific award values are not explicitly stated, the contract will cover multiple federal agencies and anticipates one aggregate award for both line items. Manufacturers or suppliers must be prepared to provide Letters of Commitment if they are not the direct manufacturer of the Colchicine tablets. The contract's structure includes a base year with four potential one-year option periods, suggesting a potential five-year total contract duration. Performance will likely be managed through the established pharmaceutical distribution channels, with delivery and fulfillment coordinated across multiple federal healthcare systems. The procurement falls under NAICS category 325412 (Pharmaceutical Preparation Manufacturing) and PSC category 6505 (Drugs and Biologicals), indicating a specialized pharmaceutical supply contract.